HUP9800719A2 - N-helyettesített azaheterociklusos karboxilsavak és észtereik, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények - Google Patents

N-helyettesített azaheterociklusos karboxilsavak és észtereik, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9800719A2
HUP9800719A2 HU9800719A HUP9800719A HUP9800719A2 HU P9800719 A2 HUP9800719 A2 HU P9800719A2 HU 9800719 A HU9800719 A HU 9800719A HU P9800719 A HUP9800719 A HU P9800719A HU P9800719 A2 HUP9800719 A2 HU P9800719A2
Authority
HU
Hungary
Prior art keywords
esters
carboxylic acids
soles
producing
pharmaceutical compositions
Prior art date
Application number
HU9800719A
Other languages
English (en)
Inventor
Henrik Sune Andersen
Knud Erik Andersen
Florenzio Zaragossa Dörwald
Rolf Hohlweg
Tine Krogh Jorgensen
Peter Madsen
Uffe Bang Olsen
Zdenék Polivka
Alexandra Silhánková
Karel Sindelár
Svend Treppendahl
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP9800719A2 publication Critical patent/HUP9800719A2/hu
Publication of HUP9800719A3 publication Critical patent/HUP9800719A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A jelen találmány tárgyát az új (I) általánős képletű vegyületekképezik, amely képletben Z jelentése az (a), (b), (c), (d), (e), (f),(g), (h), (i), (j) és (k) képletű csőpőrtők valamelyike, X jelentése -O-, -S-, -(CR6R7)-, -CH2-CH2-, -CH=CH-C2-, -CH2-CH=CH-, CH2-(C=O)-, -(C=O)-CH2-, -(CH2)3-, -CH=CH-, -N(R8)-(C=O)-, -(C=O)-, N(R8)-, -O-CH2-, -CH2-O-, -S-CH2-, -CH2-S-, -(C=O)-, -N(R9)- vagy -(S=O)-csőpőrt;Y jelentése >N-CH2-, >CH-CH2- vagy >C=CH-csőpőrt, R3 jelentése -(CH2)mOH vagy -(CH2)pCOR4 csőpőrt; Az (I) általánős képletű vegyületekN-helyettesített azaheterőciklűsős karbőxilsavak és azők észterei,amelyekben egy helyettesített alkil lánc képezi részét az N-helyettesítőnek, illetve azők sói. A találmány tárgyát képezik tővábbáaz azők előállítására szőlgáló eljárásők, az azőkat tartalmazógyógyszerkészítmények, valamint azők alkalmazása őlyan fájdalmashyperalgesiás és/vagy gyűlladásős állapőtők klinikai kezelésére,amelyek esetében az idegi eredetű fájdalőm vagy gyűlladáskialakűlásában a C-szálak játszanak patőfiziőlógiai szerepet. ŕ
HU9800719A 1995-04-07 1996-04-01 N-substituted azaheterocyclic carboxylic acids and esters, process for producing them, use and pharmaceutical compositions containing the same HUP9800719A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK40595 1995-04-07
DK100595 1995-09-11

Publications (2)

Publication Number Publication Date
HUP9800719A2 true HUP9800719A2 (hu) 1999-06-28
HUP9800719A3 HUP9800719A3 (en) 1999-09-28

Family

ID=26063928

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800719A HUP9800719A3 (en) 1995-04-07 1996-04-01 N-substituted azaheterocyclic carboxylic acids and esters, process for producing them, use and pharmaceutical compositions containing the same

Country Status (22)

Country Link
US (1) US5874428A (hu)
EP (1) EP0820451B1 (hu)
JP (1) JPH11503127A (hu)
KR (1) KR100466915B1 (hu)
CN (1) CN1152030C (hu)
AR (1) AR007759A1 (hu)
AT (1) ATE231144T1 (hu)
AU (1) AU708010B2 (hu)
CA (1) CA2217197A1 (hu)
CZ (1) CZ291294B6 (hu)
DE (1) DE69625806T2 (hu)
DK (1) DK0820451T3 (hu)
ES (1) ES2191090T3 (hu)
HU (1) HUP9800719A3 (hu)
IL (1) IL117810A (hu)
MX (1) MX9707531A (hu)
NO (1) NO974605L (hu)
PL (1) PL187171B1 (hu)
RU (1) RU2244713C2 (hu)
TW (1) TW419463B (hu)
UA (1) UA54385C2 (hu)
WO (1) WO1996031498A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239148B1 (en) * 1994-01-04 2001-05-29 Novo Nordisk A/S N-substituted azaheterocyclic carboxylic acids and esters thereof
EP0920306A2 (en) 1996-07-12 1999-06-09 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ZA978792B (en) * 1996-10-04 1998-04-06 Novo Nordisk As N-substituted azaheterocyclic compounds.
IL129123A (en) * 1996-10-04 2004-07-25 Novo Nordisk As Piperzines 1, 4 - Imaging methods, methods for their preparation and their use in the preparation of medicinal preparations
US6048856A (en) * 1997-12-17 2000-04-11 Novo Nordisk A/S Heterocyclic compounds
JP2002508353A (ja) * 1997-12-17 2002-03-19 ノボ ノルディスク アクティーゼルスカブ 新規ヘテロ環式化合物
US6509346B2 (en) * 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) * 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ES2251176T3 (es) * 1998-01-21 2006-04-16 Millennium Pharmaceuticals, Inc. Antagonistas del receptor de quimioquina y procedimientos de uso de los mismos.
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
JP2002506863A (ja) * 1998-03-17 2002-03-05 ノボ ノルディスク アクティーゼルスカブ 新規ヘテロ環式化合物
US6214816B1 (en) 1998-03-17 2001-04-10 Novo Nordisk A/S Heterocyclic compounds
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7541365B2 (en) * 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
EA009296B1 (ru) 2003-04-24 2007-12-28 Инсайт Корпорейшн Производные азаспироалканов в качестве ингибиторов металлопротеаз
US20070066570A1 (en) * 2003-06-16 2007-03-22 Michael Solomon Methods for treating sleep disorders
EP2041088B1 (en) 2006-06-28 2014-01-08 Amgen Inc. Glycine transporter-1 inhibitors
JP7471818B2 (ja) * 2016-08-18 2024-04-22 ヴィダック ファーマ リミテッド ピペラジン誘導体、医薬組成物、及びその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99690C (hu) * 1956-11-15
FR1296519A (fr) * 1959-05-05 1962-06-22 Abbott Lab Procédé pour la préparation de phénothiazines substituées sur l'azote, de préférence par un groupe pyrrolidinoalkyle substitué
DE1159954B (de) * 1961-11-25 1963-12-27 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
CH454871A (de) * 1964-01-24 1968-04-30 Geigy Ag J R Verfahren zur Herstellung von neuen Salzen der Embonsäure
GB1517385A (en) * 1975-08-29 1978-07-12 Eisai Co Ltd Phenothiazine derivatives
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds

Also Published As

Publication number Publication date
PL187171B1 (pl) 2004-05-31
TW419463B (en) 2001-01-21
AU5100396A (en) 1996-10-23
IL117810A0 (en) 1996-08-04
UA54385C2 (uk) 2003-03-17
NO974605L (no) 1997-12-04
KR19980703684A (ko) 1998-12-05
AU708010B2 (en) 1999-07-29
IL117810A (en) 2001-09-13
DE69625806T2 (de) 2004-01-22
CZ316497A3 (cs) 1998-03-18
DK0820451T3 (da) 2003-05-12
RU2244713C2 (ru) 2005-01-20
DE69625806D1 (de) 2003-02-20
CN1183781A (zh) 1998-06-03
CN1152030C (zh) 2004-06-02
HUP9800719A3 (en) 1999-09-28
MX9707531A (es) 1997-11-29
KR100466915B1 (ko) 2005-04-14
WO1996031498A1 (en) 1996-10-10
NO974605D0 (no) 1997-10-06
ATE231144T1 (de) 2003-02-15
AR007759A1 (es) 1999-11-24
JPH11503127A (ja) 1999-03-23
CA2217197A1 (en) 1996-10-10
US5874428A (en) 1999-02-23
EP0820451B1 (en) 2003-01-15
ES2191090T3 (es) 2003-09-01
CZ291294B6 (cs) 2003-01-15
EP0820451A1 (en) 1998-01-28
PL322722A1 (en) 1998-02-16

Similar Documents

Publication Publication Date Title
HUP9800719A2 (hu) N-helyettesített azaheterociklusos karboxilsavak és észtereik, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0401339A2 (hu) Új 4-anilino-3-kinolinkarboxamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AR029466A1 (es) Nitrilos de dipeptidos, su proceso de sintesis y su uso para la preparacion de un medicamento en enfermedades en la cual la catepsina k este implicada
AU9189301A (en) Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments
HUP0002347A2 (hu) Hidantoin-, oxazol- és pirrolszármazékok alkalmazása gyulladásos betegségek kezelésére alkalmazható gyógyszerkészítmények előállítására
ATE69378T1 (de) Pharmazeutische zusammensetzungen.
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
HUP0402022A2 (hu) Szubsztituált fenil-propionsav-származékok mint a humán peroxiszóma proliferátor-aktivált receptor alfa (PPAR) agonistái és ezeket tartalmazó gyógyszerkészítmények
DE69531213D1 (de) Neue heterocyclische verbindungen, verfahren zu deren herstellung sowie medizinische verwendung
PT828724E (pt) Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2
HUP0401192A2 (hu) Fényérzékenyítő szer alkalmazása sebek kezelésére adható gyógyászati készítmény előállítására
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0400732A2 (hu) Gyógyászatilag hatékony uridin-észterek
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
HUP9802762A2 (hu) Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
HUP0000720A2 (hu) Imidazo [1,2-a] piridinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9901823A2 (hu) Új aril-glicin-amid-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
SE8406202D0 (sv) Framstellning av penicillansyraderivat
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
JPH0253765A (ja) 新規化合物、その製法及びそれを含む医薬組成物
ATE201021T1 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
BG100246A (en) N-substituted azaheterocylic carboxylic acids and their esters
MY160429A (en) 2, 5-disubstituted 3-mercaptopentanoic acid
HUP0202114A2 (hu) Benzoesavval szubsztituált benzopiránok alkalmazása atherosclerosis kezelésére alkalmas gyógyszerkészítményekben és a készítmények

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees